Teladoc Health, Inc. (NYSE:TDOC) Shares Acquired by Federated Hermes Inc.

Federated Hermes Inc. grew its stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 232.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 337,597 shares of the health services provider's stock after purchasing an additional 236,102 shares during the quarter. Federated Hermes Inc. owned approximately 0.20% of Teladoc Health worth $3,069,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. Y Intercept Hong Kong Ltd acquired a new stake in Teladoc Health in the 3rd quarter worth about $152,000. Geode Capital Management LLC boosted its stake in shares of Teladoc Health by 1.5% in the third quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider's stock worth $36,042,000 after acquiring an additional 56,864 shares during the last quarter. Versant Capital Management Inc increased its position in shares of Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock worth $29,000 after purchasing an additional 2,441 shares in the last quarter. Smith Anglin Financial LLC acquired a new position in Teladoc Health in the 4th quarter valued at $108,000. Finally, Arkadios Wealth Advisors acquired a new position in Teladoc Health in the 4th quarter valued at $115,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Wall Street Analyst Weigh In

TDOC has been the subject of a number of recent research reports. Royal Bank of Canada increased their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the company an "outperform" rating in a research report on Friday, January 24th. Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a report on Thursday, February 27th. The Goldman Sachs Group lowered their target price on Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a report on Monday, March 3rd. Oppenheimer cut their price target on Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a report on Friday, January 24th. Finally, Piper Sandler lowered their price objective on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday, February 27th. Eleven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $10.94.

Insider Activity

In related news, insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the transaction, the insider now owns 64,308 shares in the company, valued at $541,473.36. The trade was a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.95% of the company's stock.

Teladoc Health Trading Down 1.1 %

TDOC traded down $0.08 during mid-day trading on Friday, hitting $6.83. 3,830,334 shares of the stock were exchanged, compared to its average volume of 6,235,796. The company has a market cap of $1.20 billion, a PE ratio of -1.18 and a beta of 1.73. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The firm's fifty day moving average is $9.30 and its two-hundred day moving average is $9.64. Teladoc Health, Inc. has a 1-year low of $6.61 and a 1-year high of $15.21.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.49 million during the quarter, compared to analysts' expectations of $639.44 million. Equities analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.